Nanosilver: a nanoproduct in medical application.
By Xiao Chen, H. Schluesener. Toxicology Letters, 2008
1,925 citations recorded by the source corpus.
Subfields: Health, Toxicology and Mutagenesis, Materials Chemistry, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/e1b3e4c2b6d0e253bfb03c6ef9d2e1ea7ee4963c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Health, Toxicology and Mutagenesis
In Materials Chemistry
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Cellular responses induced by silver nanoparticles: In vitro studies. (2008, background): “Even thoughnanosilver-based wound dressings have received approval for clinical applications their possibledermal toxicity is reported tobeamatter of concern (Chen and Schluesener, 2008).”
- Silver nanoparticles: the powerful nanoweapon against multidrug‐resistant bacteria (2012, methodology): “But with the advent of antibiotics progress, the medical applications of silver as antimicrobial were declined (Castellano et al. 2007; Chen and Schluesener 2008).”
- Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release (2014, background): “have gained attention for medical imaging and biosensing purposes [4,5].”
- Agglomeration, isolation and dissolution of commercially manufactured silver nanoparticles in aqueous environments (2009, background): “Due to its antimicrobial properties, silver is commonly used in pharmaceuticals, medicines, cleaning (antibacterial soaps), water purification, and numerous commercial products and processes (Chen and Schluesener 2008).”